Innovation and Personalized Treatments in Spine Tumor Surgery: Pathology, Biomarkers and Genetics

Johns Hopkins neurosurgeon Daniel Lubelski discusses the importance of pathology, biomarkers and genetics in treatment of spine tumors. Immunotherapy and targeted therapies are used to approach tumors that have been bio-banked and gene-sequenced, resulting in a tailored treatment plan. This, combined with advanced medical and surgical options, is leading to the best possible outcomes for patients with spine tumors.

Created by

Johns Hopkins Medicine

Related Presenters

Daniel Lubelski, M.D.

Daniel Lubelski, M.D.

Director of Spine Tumor Surgery, Department of Neurosurgery

Assistant Professor of Neurosurgery

View full profile